The p53 transcription factor modulates microglia behavior through microRNA-dependent regulation of c-Maf

Journal of Immunology

Volumn 192, Issue 1, 2014, Pages 358-366

  Su, Wei ^a   Hopkins, Stephanie ^a   Nesser, Nicole K ^a,b   Sopher, Bryce ^a   Silvestroni, Aurelio ^a   Ammanuel, Simon ^a,c   Jayadev, Suman ^a   Möller, Thomas ^a,d   Weinstein, Jonathan ^a   Garden, Gwenn A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d LUNDBECK RESEARCH USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 145; MICRORNA 155; MICRORNA 34A; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR C MAF; TWIST2 PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL ACTIVITY; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN RNA BINDING; SIGNAL TRANSDUCTION;

EID: 84891136019     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301397     Document Type: Article

References (78)

1. Aktas, O., O. Ullrich, C. Infante-Duarte, R. Nitsch, and F. Zipp. 2007. Neuronal damage in brain inflammation. Arch. Neurol. 64: 185-189.
2. Lynch, M. A. 2009. The multifaceted profile of activated microglia. Mol. Neurobiol. 40: 139-156.
3. Ponomarev, E. D., L. P. Shriver, K. Maresz, and B. N. Dittel. 2005. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. J. Neurosci. Res. 81: 374-389.
4. Ponomarev, E. D., T. Veremeyko, and H. L. Weiner. 2013. MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS. Glia 61: 91-103.
5. Rickard, A. J., and M. J. Young. 2009. Corticosteroid receptors, macrophages and cardiovascular disease. J. Mol. Endocrinol. 42: 449-459.
6. Weber, M. S., T. Prod'homme, S. Youssef, S. E. Dunn, C. D. Rundle, L. Lee, J. C. Patarroyo, O. Stüve, R. A. Sobel, L. Steinman, and S. S. Zamvil. 2007. Type II monocytes modulate T cell-mediated central nervous system autoimmune disease. Nat. Med. 13: 935-943.
7. Kigerl, K. A., J. C. Gensel, D. P. Ankeny, J. K. Alexander, D. J. Donnelly, and P. G. Popovich. 2009. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci. 29: 13435-13444.
8. Jebelli, J. D., C. Hooper, G. A. Garden, and J. M. Pocock. 2012. Emerging roles of p53 in glial cell function in health and disease. Glia 60: 515-525.
9. Lobsiger, C. S., and D. W. Cleveland. 2007. Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat. Neurosci. 10: 1355-1360.
10. Mendrysa, S. M., S. Ghassemifar, and R. Malek. 2011. p53 in the CNS: perspectives on development, stem cells, and cancer. Genes Cancer 2: 431-442.
11. Garden, G. A., W. Guo, S. Jayadev, C. Tun, S. Balcaitis, J. Choi, T. J. Montine, T. Möller, and R. S. Morrison. 2004. HIV associated neurodegeneration requires p53 in neurons and microglia. FASEB J. 18: 1141-1143.
12. Jayadev, S., B. Yun, H. Nguyen, H. Yokoo, R. S. Morrison, and G. A. Garden. 2007. The glial response to CNS HIV infection includes p53 activation and increased expression of p53 target genes. J. Neuroimmune Pharmacol. 2: 359-370.
13. Jayadev, S., N. K. Nesser, S. Hopkins, S. J. Myers, A. Case, R. J. Lee, L. A. Seaburg, T. Uo, S. P. Murphy, R. S. Morrison, and G. A. Garden. 2011. Transcription factor p53 influences microglial activation phenotype. Glia 59: 1402-1413.
14. Davenport, C. M., I. G. Sevastou, C. Hooper, and J. M. Pocock. 2010. Inhibiting p53 pathways in microglia attenuates microglial-evoked neurotoxicity following exposure to Alzheimer peptides. J. Neurochem. 112: 552-563.
15. Moestrup, S. K., and H. J. Møller. 2004. CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Ann. Med. 36: 347-354.
16. Bentwich, I., A. Avniel, Y. Karov, R. Aharonov, S. Gilad, O. Barad, A. Barzilai, P. Einat, U. Einav, E. Meiri, et al. 2005. Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet. 37: 766-770.
17. Perruisseau-Carrier, C., M. Jurga, N. Forraz, and C. P. McGuckin. 2011. miRNAs stem cell reprogramming for neuronal induction and differentiation. Mol. Neurobiol. 43: 215-227.
18. Ponomarev, E. D., T. Veremeyko, N. Barteneva, A. M. Krichevsky, and H. L. Weiner. 2011. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-a-PU.1 pathway. Nat. Med. 17: 64-70.
19. Lewis, B. P., C. B. Burge, and D. P. Bartel. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
20. Miranda, K. C., T. Huynh, Y. Tay, Y.-S. Ang, W.-L. Tam, A. M. Thomson, B. Lim, and I. Rigoutsos. 2006. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 126: 1203-1217.
21. He, M., Z. Xu, T. Ding, D.-M. Kuang, and L. Zheng. 2009. MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C/EBPbeta. [beta] Cell. Mol. Immunol. 6: 343-352.
22. Bird, L. 2011. Immune regulation: microRNAs keep microglia quiet. Nat. Rev. Immunol. 11: 76-77.
23. Dai, R., and S. A. Ahmed. 2011. MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl. Res. 157: 163-179.
24. Feng, Z., C. Zhang, R. Wu, and W. Hu. 2011. Tumor suppressor p53 meets microRNAs. J. Mol. Cell Biol. 3: 44-50.
25. Suzuki, H. I., K. Yamagata, K. Sugimoto, T. Iwamoto, S. Kato, and K. Miyazono. 2009. Modulation of microRNA processing by p53. Nature 460: 529-533.
26. Chang, T.-C., E. A. Wentzel, O. A. Kent, K. Ramachandran, M. Mullendore, K. H. Lee, G. Feldmann, M. Yamakuchi, M. Ferlito, C. J. Lowenstein, et al. 2007. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell 26: 745-752.
27. He, L., X. He, L. P. Lim, E. de Stanchina, Z. Xuan, Y. Liang, W. Xue, L. Zender, J. Magnus, D. Ridzon, et al. 2007. A microRNA component of the p53 tumour suppressor network. Nature 447: 1130-1134.
28. Raver-Shapira, N., E. Marciano, E. Meiri, Y. Spector, N. Rosenfeld, N. Moskovits, Z. Bentwich, and M. Oren. 2007. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell 26: 731-743.
29. Tarasov, V., P. Jung, B. Verdoodt, D. Lodygin, A. Epanchintsev, A. Menssen, G. Meister, and H. Hermeking. 2007. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6: 1586-1593.
30. Tazawa, H., N. Tsuchiya, M. Izumiya, and H. Nakagama. 2007. Tumorsuppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl. Acad. Sci. USA 104: 15472-15477.
31. Sachdeva, M., S. Zhu, F. Wu, H. Wu, V. Walia, S. Kumar, R. Elble, K. Watabe, and Y.-Y. Mo. 2009. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc. Natl. Acad. Sci. USA 106: 3207-3212.
32. Sachdeva, M., and Y.-Y. Mo. 2010. MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res. 70: 378-387.
33. Homma, Y., S. Cao, X. Shi, and X. Ma. 2007. The Th2 transcription factor c-Maf inhibits IL-12p35 gene expression in activated macrophages by targeting NF-kappaB nuclear translocation. J. Interferon Cytokine Res. 27: 799-808.
34. Cao, S., J. Liu, L. Song, and X. Ma. 2005. The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression in macrophages. J. Immunol. 174: 3484-3492.
35. Donehower, L. A., M. Harvey, B. L. Slagle, M. J. McArthur, C. A. Montgomery, Jr., J. S. Butel, and A. Bradley. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221.
36. Rodriguez, A., E. Vigorito, S. Clare, M. V. Warren, P. Couttet, D. R. Soond, S. van Dongen, R. J. Grocock, P. P. Das, E. A. Miska, et al. 2007. Requirement of bic/microRNA-155 for normal immune function. Science 316: 608-611.
37. Longa, E. Z., P. R. Weinstein, S. Carlson, and R. Cummins. 1989. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20: 84-91.
38. Stenzel-Poore, M. P., S. L. Stevens, Z. Xiong, N. S. Lessov, C. A. Harrington, M. Mori, R. Meller, H. L. Rosenzweig, E. Tobar, T. E. Shaw, et al. 2003. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet 362: 1028-1037.
39. Clark, W., L. Gunion-Rinker, N. Lessov, and K. Hazel. 1998. Citicoline treatment for experimental intracerebral hemorrhage in mice. Stroke 29: 2136-2140.
40. de Haas, A. H., H. W. Boddeke, N. Brouwer, and K. Biber. 2007. Optimized isolation enables ex vivo analysis of microglia from various central nervous system regions. Glia 55: 1374-1384.
41. Möller, T., U.-K. Hanisch, and B. R. Ransom. 2000. Thrombin-induced activation of cultured rodent microglia. J. Neurochem. 75: 1539-1547.
42. Cao, S., J. Liu, M. Chesi, P. L. Bergsagel, I.-C. Ho, R. P. Donnelly, and X. Ma. 2002. Differential regulation of IL-12 and IL-10 gene expression in macrophages by the basic leucine zipper transcription factor c-Maf fibrosarcoma. J. Immunol. 169: 5715-5725.
43. Rani, A., B. Afzali, A. Kelly, L. Tewolde-Berhan, M. Hackett, A. S. Kanhere, I. Pedroza-Pacheco, H. Bowen, S. Jurcevic, R. G. Jenner, et al. 2011. IL-2 regulates expression of C-MAF in human CD4 T cells. J. Immunol. 187: 3721-3729.
44. Sedgwick, J. D., S. Schwender, H. Imrich, R. Dörries, G. W. Butcher, and V. Ter Meulen. 1991. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc. Natl. Acad. Sci. USA 88: 7438-7442.
45. Daley, J. M., A. A. Thomay, M. D. Connolly, J. S. Reichner, and J. E. Albina. 2008. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol. 83: 64-70.
46. Carson, M. J., C. R. Reilly, J. G. Sutcliffe, and D. Lo. 1998. Mature microglia resemble immature antigen-presenting cells. Glia 22: 72-85.
47. Riley, T., E. Sontag, P. Chen, and A. Levine. 2008. Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell Biol. 9: 402-412.
48. Liu, F. Y., X. C. Tang, M. Deng, P. Chen, W. Ji, X. Zhang, L. Gong, Z. Woodward, J. Liu, L. Zhang, et al. 2012. The tumor suppressor p53 regulates c-Maf and Prox-1 to control lens differentiation. Curr. Mol. Med. 12: 917-928.
49. Mukhopadhyay, S., Y. Chen, M. Sankala, L. Peiser, T. Pikkarainen, G. Kraal, K. Tryggvason, and S. Gordon. 2006. MARCO, an innate activation marker of macrophages, is a class A scavenger receptor for Neisseria meningitidis. Eur. J. Immunol. 36: 940-949.
50. Sharabi, A. B., M. Aldrich, D. Sosic, E. N. Olson, A. D. Friedman, S.-H. Lee, and S.-Y. Chen. 2008. Twist-2 controls myeloid lineage development and function. PLoS Biol. 6: e316.
51. Zambelli, F., G. Pesole, and G. Pavesi. 2009. Pscan: finding over-represented transcription factor binding site motifs in sequences from co-regulated or co-expressed genes. Nucleic Acids Res. 37(Web Server issue): W247-52.
52. Colton, C. A., R. T. Mott, H. Sharpe, Q. Xu, W. E. Van Nostrand, and M. P. Vitek. 2006. Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J. Neuroinflammation 3: 27.
53. Colton, C. A. 2009. Heterogeneity of microglial activation in the innate immune response in the brain. J. Neuroimmune Pharmacol. 4: 399-418.
54. Colton, C., and D. M. Wilcock. 2010. Assessing activation states in microglia. CNS Neurol. Disord. Drug Targets 9: 174-191.
55. Arnaud, L., N. K. Robakis, and M. E. Figueiredo-Pereira. 2006. It may take inflammation, phosphorylation and ubiquitination to "tangle" in Alzheimer's disease. Neurodegener. Dis. 3: 313-319.
56. Salmina, A. B. 2009. Neuron-glia interactions as therapeutic targets in neurodegeneration. J. Alzheimers Dis. 16: 485-502.
57. Whitton, P. S. 2007. Inflammation as a causative factor in the aetiology of Parkinson's disease. Br. J. Pharmacol. 150: 963-976.
58. Boillée, S., K. Yamanaka, C. S. Lobsiger, N. G. Copeland, N. A. Jenkins, G. Kassiotis, G. Kollias, and D. W. Cleveland. 2006. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312: 1389-1392.
59. Schmidt, O. I., C. E. Heyde, W. Ertel, and P. F. Stahel. 2005. Closed head injury - an inflammatory disease? Brain Res. Brain Res. Rev. 48: 388-399.
60. Muir, K. W., P. Tyrrell, N. Sattar, and E. Warburton. 2007. Inflammation and ischaemic stroke. Curr. Opin. Neurol. 20: 334-342.
61. Gottlieb, T. M., and M. Oren. 1996. p53 in growth control and neoplasia. Biochim. Biophys. Acta 1287: 77-102.
62. Eizenberg, O., A. Faber-Elman, E. Gottlieb, M. Oren, V. Rotter, and M. Schwartz. 1996. p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells. Mol. Cell. Biol. 16: 5178-5185.
63. Haapajärvi, T., K. Pitkänen, M. Tsubari, and M. Laiho. 1997. p53 transactivation and protein accumulation are independently regulated by UV light in different phases of the cell cycle. Mol. Cell. Biol. 17: 3074-3080.
64. Sakaguchi, K., J. E. Herrera, S. i. Saito, T. Miki, M. Bustin, A. Vassilev, C. W. Anderson, and E. Appella. 1998. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 12: 2831-2841.
65. Motohashi, H., J. A. Shavit, K. Igarashi, M. Yamamoto, and J. D. Engel. 1997. The world according to Maf. Nucleic Acids Res. 25: 2953-2959.
66. Kataoka, K. 2007. Multiple mechanisms and functions of maf transcription factors in the regulation of tissue-specific genes. J. Biochem. 141: 775-781.
67. Agnello, D., C. S. Lankford, J. Bream, A. Morinobu, M. Gadina, J. J. O'Shea, and D. M. Frucht. 2003. Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J. Clin. Immunol. 23: 147-161.
68. Nakamura, M., M. Hamada, K. Hasegawa, M. Kusakabe, H. Suzuki, D. R. Greaves, T. Moriguchi, T. Kudo, and S. Takahashi. 2009. c-Maf is essential for the F4/80 expression in macrophages in vivo. Gene 445: 66-72.
69. Nishikawa, K., T. Nakashima, S. Takeda, M. Isogai, M. Hamada, A. Kimura, T. Kodama, A. Yamaguchi, M. J. Owen, S. Takahashi, and H. Takayanagi. 2010. Maf promotes osteoblast differentiation in mice by mediating the age-related switch in mesenchymal cell differentiation. J. Clin. Invest. 120: 3455-3465.
70. Louafi, F., R. T. Martinez-Nunez, and T. Sanchez-Elsner. 2010. MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-b. J. Biol. Chem. 285: 41328-41336.
71. Martinez-Nunez, R. T., F. Louafi, and T. Sanchez-Elsner. 2011. The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor a1 (IL13Ralpha1). J. Biol. Chem. 286: 1786-1794.
72. Ruffell, D., F. Mourkioti, A. Gambardella, P. Kirstetter, R. G. Lopez, N. Rosenthal, and C. Nerlov. 2009. A CREB-C/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair. Proc. Natl. Acad. Sci. USA 106: 17475-17480.
73. Cardoso, A. L., J. R. Guedes, L. Pereira de Almeida, and M. C. Pedroso de Lima. 2012. miR-155 modulates microglia-mediated immune response by down-regulating SOCS-1 and promoting cytokine and nitric oxide production. Immunology 135: 73-88.
74. Yang, J., S. A. Mani, J. L. Donaher, S. Ramaswamy, R. A. Itzykson, C. Come, P. Savagner, I. Gitelman, A. Richardson, and R. A. Weinberg. 2004. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927-939.
75. Ansieau, S., J. Bastid, A. Doreau, A.-P. Morel, B. P. Bouchet, C. Thomas, F. Fauvet, I. Puisieux, C. Doglioni, S. Piccinin, et al. 2008. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 14: 79-89.
76. Šošić, D., J. A. Richardson, K. Yu, D. M. Ornitz, and E. N. Olson. 2003. Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity. Cell 112: 169-180.
77. Chen, Z. F., and R. R. Behringer. 1995. Twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev. 9: 686-699.
78. Ho, I.-C., D. Lo, and L. H. Glimcher. 1998. c-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin 4-dependent and -independent mechanisms. J. Exp. Med. 188: 1859-1866.